Connection
Steven Abman to Cyclic Nucleotide Phosphodiesterases, Type 5
This is a "connection" page, showing publications Steven Abman has written about Cyclic Nucleotide Phosphodiesterases, Type 5.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.212 |
|
|
|
-
Abman SH. Pulmonary hypertension in older children: new approaches and therapies. Paediatr Respir Rev. 2006; 7 Suppl 1:S177-9.
Score: 0.071
-
Deruelle P, Grover TR, Abman SH. Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep. Am J Physiol Lung Cell Mol Physiol. 2005 Nov; 289(5):L798-806.
Score: 0.066
-
Deruelle P, Grover TR, Storme L, Abman SH. Effects of BAY 41-2272, a soluble guanylate cyclase activator, on pulmonary vascular reactivity in the ovine fetus. Am J Physiol Lung Cell Mol Physiol. 2005 Apr; 288(4):L727-33.
Score: 0.064
-
Hanson KA, Ziegler JW, Rybalkin SD, Miller JW, Abman SH, Clarke WR. Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity. Am J Physiol. 1998 11; 275(5):L931-41.
Score: 0.010